SEC Form 4 · accession 0001562180-15-000781
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne Marie Cook
Officer — General Counsel
Period of report
Sep 16, 2015
Accepted (ET)
Sep 18, 2015 · 10:38 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $56.27 | Sep 16, 2015 | A | 110,000 | A | — | Sep 16, 2025 | Common Stock | 110,000 | 110,000 | D |
Explanation of responses
- F1The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. 27,500 shares will vest on September 16, 2016. The remaining shares will vest in equal monthly installments over the 36 months following September 16, 2016.